These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 15246018)

  • 21. Expression and purification of human urodilatin by small ubiquitin-related modifier fusion in Escherichia coli.
    Sun Z; Xia Z; Bi F; Liu JN
    Appl Microbiol Biotechnol; 2008 Mar; 78(3):495-502. PubMed ID: 18189135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of magnetic carboxymethyl chitosan nanoparticles and cation exchange resin for the efficient purification of lysine-tagged small ubiquitin-like modifier protease.
    Li J; Zhang Y; Shen F; Yang Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Oct; 907():159-62. PubMed ID: 22995375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Purification and activity assays for Ubc9, the ubiquitin-conjugating enzyme for the small ubiquitin-like modifier SUMO.
    Yunus AA; Lima CD
    Methods Enzymol; 2005; 398():74-87. PubMed ID: 16275321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional expression and purification of recombinant Hepcidin25 production in Escherichia coli using SUMO fusion technology.
    Sadr V; Saffar B; Emamzadeh R
    Gene; 2017 Apr; 610():112-117. PubMed ID: 28188870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression and purification of human PYY(3-36) in Escherichia coli using a His-tagged small ubiquitin-like modifier fusion.
    Fazen CH; Kahkoska AR; Doyle RP
    Protein Expr Purif; 2012 Sep; 85(1):51-9. PubMed ID: 22771863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-level expression and purification of heparin-binding epidermal growth factor (HB-EGF) with SUMO fusion.
    Lu W; Cao P; Lei H; Zhang S
    Mol Biotechnol; 2010 Mar; 44(3):198-203. PubMed ID: 19950003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The small ubiquitin-like modifier (SUMO)-conjugating system of Toxoplasma gondii.
    Braun L; Cannella D; Pinheiro AM; Kieffer S; Belrhali H; Garin J; Hakimi MA
    Int J Parasitol; 2009 Jan; 39(1):81-90. PubMed ID: 18761012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bioprocess optimization for the overproduction of catalytic domain of ubiquitin-like protease 1 (Ulp1) from S. cerevisiae in E. coli fed-batch culture.
    Babbal ; Adivitiya ; Mohanty S; Khasa YP
    Enzyme Microb Technol; 2019 Jan; 120():98-109. PubMed ID: 30396406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tandem SUMO fusion vectors for improving soluble protein expression and purification.
    Guerrero F; Ciragan A; Iwaï H
    Protein Expr Purif; 2015 Dec; 116():42-9. PubMed ID: 26297996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Construction and expression of an antimicrobial peptide scolopin 1 from the centipede venoms of Scolopendra subspinipes mutilans in Escherichia coli using SUMO fusion partner.
    Hou H; Yan W; Du K; Ye Y; Cao Q; Ren W
    Protein Expr Purif; 2013 Dec; 92(2):230-4. PubMed ID: 24145284
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ubiquitin-intein and SUMO2-intein fusion systems for enhanced protein production and purification.
    Wang Z; Li N; Wang Y; Wu Y; Mu T; Zheng Y; Huang L; Fang X
    Protein Expr Purif; 2012 Mar; 82(1):174-8. PubMed ID: 22178731
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Formation and nuclear export of preribosomes are functionally linked to the small-ubiquitin-related modifier pathway.
    Panse VG; Kressler D; Pauli A; Petfalski E; Gnädig M; Tollervey D; Hurt E
    Traffic; 2006 Oct; 7(10):1311-21. PubMed ID: 16978391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ubc9 fusion-directed SUMOylation (UFDS): a method to analyze function of protein SUMOylation.
    Jakobs A; Koehnke J; Himstedt F; Funk M; Korn B; Gaestel M; Niedenthal R
    Nat Methods; 2007 Mar; 4(3):245-50. PubMed ID: 17277783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Production of bioactive γ-glutamyl transpeptidase in Escherichia coli using SUMO fusion partner and application of the recombinant enzyme to L-theanine synthesis.
    Wang Q; Min C; Zhu F; Xin Y; Zhang S; Luo L; Yin Z
    Curr Microbiol; 2011 May; 62(5):1535-41. PubMed ID: 21327888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimization of soluble human interferon-γ production in Escherichia coli using SUMO fusion partner.
    Zhu F; Wang Q; Pu H; Gu S; Luo L; Yin Z
    World J Microbiol Biotechnol; 2013 Feb; 29(2):319-25. PubMed ID: 23054704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression and purification of human keratinocyte growth factor 2 by fusion with SUMO.
    Wu X; Nie C; Huang Z; Nie Y; Yan Q; Xiao Y; Su Z; Huang Y; Xiao J; Zeng Y; Tan Y; Feng W; Li X
    Mol Biotechnol; 2009 May; 42(1):68-74. PubMed ID: 19104760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beginning at the end with SUMO.
    Matunis MJ; Pickart CM
    Nat Struct Mol Biol; 2005 Jul; 12(7):565-6. PubMed ID: 15999109
    [No Abstract]   [Full Text] [Related]  

  • 38. High-level expression and purification of human epidermal growth factor with SUMO fusion in Escherichia coli.
    Su Z; Huang Y; Zhou Q; Wu Z; Wu X; Zheng Q; Ding C; Li X
    Protein Pept Lett; 2006; 13(8):785-92. PubMed ID: 17073723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unique binding interactions among Ubc9, SUMO and RanBP2 reveal a mechanism for SUMO paralog selection.
    Tatham MH; Kim S; Jaffray E; Song J; Chen Y; Hay RT
    Nat Struct Mol Biol; 2005 Jan; 12(1):67-74. PubMed ID: 15608651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systematic analysis of fusion and affinity tags using human aspartyl-tRNA synthetase expressed in E. coli.
    Guzzo CM; Yang DC
    Protein Expr Purif; 2007 Jul; 54(1):166-75. PubMed ID: 17434317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.